Friday, March 8, 2013

ACTC the future in bio-tech: BTX, ACTC, Geron week in review

ACTC the future in bio-tech: BTX, ACTC, Geron week in review: ACTC announced fourth quarter and year end results March 7th. Nothing said that moved the stock price. Still at 7 cents. Need money, results...

No comments:

Post a Comment